Proteomic temporal profile of human brain endothelium after oxidative stress.

Clinical Proteomics Research Center, Massachusetts General Hospital, Harvard Medial School, Boston, MA, USA.
Stroke (Impact Factor: 6.16). 01/2011; 42(1):37-43. DOI: 10.1161/STROKEAHA.110.585703
Source: PubMed

ABSTRACT because brain endothelial cells exist at the neurovascular interface, they may serve as cellular reporters of brain dysfunction by releasing biomarkers into the circulation.
we used proteomic techniques to screen conditioned media from human brain endothelial cultures subjected to oxidative stress induced by nitric oxide over 24 hours. Plasma samples from human stroke patients were analyzed by enzyme-linked immunosorbent assay.
in healthy endothelial cells, interaction mapping demonstrated cross-talk involving secreted factors, membrane receptors, and matrix components. In oxidatively challenged endothelial cells, networks of interacting proteins failed to emerge. Instead, inflammatory markers increased, secreted factors oscillated over time, and endothelial injury repair was manifested as changes in factors related to matrix integrity. Elevated inflammatory markers included heat shock protein, chemokine ligand-1, serum amyloid-A1, annexin-A5, and thrombospondin-1. Neurotrophic factors (prosaposin, nucleobindin-1, and tachykinin precursors) peaked at 12 hours, then rapidly decreased by 24 hours. Basement membrane components (fibronectin, desomoglein, profiling-1) were decreased. Cytoskeletal markers (actin, vimentin, nidogen, and filamin B) increased over time. From this initial analysis, the high-ranking candidate thrombospondin-1 was further explored in human plasma. Acute ischemic stroke patients had significantly higher thrombospondin-1 levels within 8 hours of symptom onset compared to controls with similar clinical risk factors (659 ± 81 vs 1132 ± 98 ng/mL; P<0.05; n=20).
screening of simplified cell culture systems may aid the discovery of novel biomarkers in clinical neurovascular injury. Further collaborative efforts are warranted to discover and validate more candidates of interest.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The blood-brain barrier (BBB) is formed by brain capillary endothelial cells linked together via complex tight junctions, and serves to prevent entry of drugs into the brain. Multiple transporters are expressed at the BBB, where they control exchange of materials between the circulating blood and brain interstitial fluid, thereby supporting and protecting the CNS. An understanding of the BBB is necessary for efficient development of CNS-acting drugs and to identify potential drug targets for treatment of CNS diseases. Quantitative targeted proteomics can provide detailed information on protein expression levels at the BBB. The present review highlights the latest applications of quantitative targeted proteomics in BBB research, specifically to evaluate species and in vivo-in vitro differences, and to reconstruct in vivo transport activity. Such a BBB quantitative proteomics approach can be considered as pharmacoproteomics.
    Expert Review of Proteomics 04/2014; · 3.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: While neurovascular diseases such as ischemic and hemorrhagic stroke are the leading causes of disability in the world, the repertoire of therapeutic interventions has remained remarkably limited. There is a dire need to develop new diagnostic, prognostic, and therapeutic options. The study of proteomics is particularly enticing for cerebrovascular diseases such as stroke, which most likely involve multiple gene interactions resulting in a wide range of clinical phenotypes. Currently, rapidly progressing neuro-proteomic techniques have been employed in clinical and translational research to help identify biologically relevant pathways, to understand cerebrovascular pathophysiology, and to develop novel therapeutics and diagnostics. Future integration of proteomic with genomic, transcriptomic, and metabolomic studies will add new perspectives to better understand the complexities of neurovascular injury. Here we review cerebrovascular proteomics research in both preclinical (animal, cell culture) and clinical (blood, urine, CSF, microdialyates, tissue) studies. We will also discuss the rewards, challenges and future directions for the application of proteomics technology to the study of various disease phenotypes. To capture the dynamic range of cerebrovascular injury and repair with a translational targeted and discovery approach, we emphasize the importance of complementing innovative proteomic technology with existing molecular biology models in pre-clinical studies, and the need to advance pharmaco-proteomics to directly probe clinical physiology and gauge therapeutic efficacy at the bedside.
    Electrophoresis 10/2012; · 3.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Methionine Sulfoxide Reductases (Msrs) are key enzymes proficient in catalyzing the reduction of oxidized methionines. This reductive trait is essential to maintain cellular redox homeostasis from bacteria to mammals and is also regarded as a potential mechanism to regulate protein activities and signaling pathways, considering the inactivating effects that can be induced by methionine oxidation. In this study, we have generated stable human embryonic kidney HEK293 clones with an altered Msr system by silencing the expression of the main Msr elements - either MsrA, MsrB1 or MsrB2. The isolated clones - the single mutants MsrA, MsrB1, MsrB2 and double mutant MsrA/B1 - show a reduced Msr activity and an exacerbated sensitivity towards oxidative stress. A 2 Dimensional Difference In-Gel Electrophoresis (DIGE) analysis was performed on the Msr-silenced cells grown under basal conditions or submitted to oxidative stress. This proteomic analysis revealed that the disruption of the Msr system mainly affects proteins with redox, cytoskeletal or protein synthesis and maintenance roles. Interestingly, most of the proteins found altered in the different Msr mutants were also identified as potential Msr substrates and have been associated with redox or aging processes in previous studies. This study, through an extensive analysis of Msr-inhibited mutants, offers a valuable input on the cellular network of a crucial maintenance system such as Methionine Sulfoxide Reductases.
    Free Radical Biology & Medicine 08/2013; · 5.27 Impact Factor